Serum galectin-3 levels are decreased in schizophrenia.

Creative Commons License

Kiliç F., Işik Ü., Demirdaş A., Usta A.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), vol.42, pp.398-402, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 42
  • Publication Date: 2020
  • Doi Number: 10.1590/1516-4446-2019-0699
  • Journal Name: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, Academic Search Premier, Fuente Academica Plus, BIOSIS, EMBASE, MEDLINE, Psycinfo, Directory of Open Access Journals
  • Page Numbers: pp.398-402
  • Keywords: Schizophrenia, galectin-3, serum level, neuroinflammation, EXPRESSION, CYTOKINE, ANGIOGENESIS, INFLAMMATION, PSYCHOSIS, SEVERITY, SYMPTOMS, CELLS
  • Süleyman Demirel University Affiliated: Yes


Objective: To determine whether changes in serum galectin-3 (gal-3) concentrations in schizophrenia patients have etiopathogenetic importance. Since very little research has assessed the connection between galectins and schizophrenia, we wanted to examine alterations in the inflammatory marker gal-3 in schizophrenia and investigate possible correlations between clinical symptomatology and serum concentrations.